Technology | May 07, 2013

UltraSPECT Partners with PharmaLogic to Offer Dose Reduction Solution

Hospitals and their patients to benefit from reduced dose and faster exams

May 7, 2013 — UltraSPECT has announced its distribution agreement with PharmaLogic for the sale of UltraSPECT’s cardiac and bone imaging applications. The agreement will enable PharmaLogic to provide its hospitals and imaging centers with access to UltraSPECT’s Xpress line of products for lower radiation dose with no diminished image quality.

“UltraSPECT’s proprietary Wide-Beam Reconstruction technology enables our customers to achieve significant radiation dose reduction combined with greater patient comfort and higher throughput capacity,” said Steve Chilinski, president and CEO of PharmaLogic. “Even better, this technology can be easily implemented by retrofitting our customers’ existing facilities without the cost of new imaging camera systems."

Through the use of UltraSPECT’s innovative Wide-Beam Reconstruction (WBR) technology, the products in the company’s portfolio of solutions can provide two unique advantages. They significantly reduce the standard radiopharmaceutical dose requirements for cardiac and bone nuclear medicine imaging exams and/or cut the imaging procedure time in half while maintaining the image quality the facility is accustomed to. Many times they even enhance the image resolution. The company’s Xpress3.Cardiac solution provides benefits — enabling nuclear exams to be performed with 50 percent reduction in both dose and procedure time.

Both patients and technologists benefit from these improvements. With shorter exam times, patient comfort is increased with reduced risk of artifacts from patient movement. Higher image resolution provides greater lesion localization, raising diagnostic confidence and precision. For many UltraSPECT users, the WBR technology results in higher patient throughput for enhanced equipment utilization, higher revenues and greater patient satisfaction and referrals.

UltraSPECT’s product line, utilizing WBR technology, is compatible with most major manufacturers’ nuclear medicine systems as well as clinical software packages.

For more information: www.ultraspect.com

Related Content

Technological Advancements Expected to Drive Virtual Reality Growth in Healthcare
News | Advanced Visualization | April 04, 2019
Increasing demand for innovative diagnostic techniques, neurological disorders and increasing disease awareness are...
Medivis Unveils AnatomyX Augmented Reality Education Platform
Technology | Advanced Visualization | April 02, 2019
Medical imaging and visualization company Medivis announced the launch of AnatomyX, its augmented reality (AR) platform...
Sponsored Content | Videos | Advanced Visualization | April 01, 2019
GE Healthcare goes beyond core equipment maintenance to help clients solve some of their most important asset and cli
Novarad Names New President
News | Enterprise Imaging | March 29, 2019
Medical imaging software company Novarad announced that it has appointed Paul Jensen as company president.
NZ Technologies Announces First Peer-Reviewed Paper on TIPSO AirPad
News | Interventional Radiology | March 25, 2019
NZ Technologies Inc. announced the first published clinical review on its TIPSO technology’s ability to provide...
NIH Study of Brain Energy Patterns Provides New Insights into Alcohol Effects

NIH scientists present a new method for combining measures of brain activity (left) and glucose consumption (right) to study regional specialization and to better understand the effects of alcohol on the human brain. Image courtesy of Ehsan Shokri-Kojori, Ph.D., of NIAAA.

News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
DrChrono and 3D4Medical Partner to Bring 3-D Interactive Modeling to Physician Practices
News | Advanced Visualization | March 18, 2019
DrChrono Inc. and 3D4Medical have teamed up so practices across the United States can access 3-D interactive modeling...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...